| P2093 | author name string | Ahmad Gharehbaghian | |
| | Mohsen Hamidpour | |
| | Ali Akbar Khadem-Maboudi | |
| | Morteza Salimian | |
| | Razie Mahmoodian | |
| P2860 | cites work | Microparticle and Atherothrombotic Diseases | Q28087049 |
| | Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies | Q28196175 |
| | Platelet activation in type 2 diabetes mellitus | Q28210554 |
| | Desensitization of G-protein-coupled receptors in the cardiovascular system | Q33547221 |
| | Platelet dysfunction in type 2 diabetes | Q34319534 |
| | Inflammation in nonhealing diabetic wounds: the space-time continuum does matter | Q34326241 |
| | Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective | Q35174193 |
| | Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. | Q35540861 |
| | Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a | Q36609739 |
| | Factors contributing to increased platelet reactivity in people with diabetes | Q37139534 |
| | Hyperglycemia: a prothrombotic factor? | Q37759238 |
| | Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis | Q37778858 |
| | Cellular mechanisms underlying the formation of circulating microparticles | Q37821168 |
| | Diabetes and antiplatelet therapy in acute coronary syndrome. | Q37846051 |
| | Microparticles: targets and tools in cardiovascular disease. | Q37906852 |
| | Prothrombotic changes in diabetes mellitus | Q38102944 |
| | Emerging role of extracellular vesicles in inflammatory diseases. | Q38188861 |
| | Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles | Q38632361 |
| | Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype. | Q38674677 |
| | Vascular complications in diabetes: Microparticles and microparticle associated microRNAs as active players. | Q38739566 |
| | Rapid resensitization of purinergic receptor function in human platelets. | Q39976986 |
| | P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. | Q40467377 |
| | Evidence for abnormal platelet glycoprotein expression in diabetes mellitus | Q41194133 |
| | Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study | Q42489566 |
| | Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. | Q43787195 |
| | Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood | Q44620766 |
| | From platelet dust to gold dust: physiological importance and detection of platelet microvesicles. | Q50891146 |
| | The platelet "sugar high" in diabetes | Q61784013 |
| | ADP-induced refractory state of platelets in vitro. I. Methodological studies on aggregation in platelet rich plasma | Q67332070 |
| | Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors | Q73043968 |
| | Significance of chemokines and activated platelets in patients with diabetes | Q74261220 |
| | The potential role of platelet microparticles in atherosclerosis | Q81438673 |
| | Platelet abnormalities in diabetes mellitus | Q85156103 |
| | Diagnosis and classification of diabetes mellitus | Q85777959 |
| P433 | issue | 1 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 62 | |
| P577 | publication date | 2019-06-14 | |
| P1433 | published in | BMC Endocrine Disorders | Q4835945 |
| P1476 | title | The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus. | |
| P478 | volume | 19 | |